Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $52.6 million versus the consensus estimate of $52.7 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.